Diagnostic laboratories play a central role in the recognition of new and emerging infections. The identification of the severe acute respiratory syndrome (SARS) coronavirus in 2003 highlighted how modern diagnostic tools and collaboration between clinicians, public health professionals, and laboratorians can lead to the rapid characterization of a new respiratory pathogen. 1 Similarly, the development and rapid dissemination of a polymerase chain reaction (PCR) method to detect the novel H1N1 influenza A strain by the US Centers for Disease Control and Prevention in 2009, relied on the most recent diagnostic technology and played an important role in the response to the latest influenza pandemic. 2 These events remind us of how much recent developments in diagnostics have improved our ability to identify respiratory 